Cellorgane® Multi-Complex 3G Formula 5 Kidney - Nephrons

Renal Function Genitourinary

Problem

With age, organ function progressively decreases due to cell deterioration, caused mainly by oxidative stress; this generates vitality and quality of life losses.
This organic sub function predisposes to chronic degenerative diseases.
Damage by oxidative stress, kidney problems and hyperglycemia.

Uses

Incipient renal failure, Anemia, Diabetes Mellitus type II, Hypertension, mild to moderate Heart failure and Aging

Solution

The contribution of cellular cytokines and growth factors in embryonic extracts has a refreshing and revitalizing effect at the cellular level, which increases the specific functionality of the organ to be treated.
Antioxidant enzymes neutralize free radicals, thereby reducing damage from oxidative stress.

Composition

Oral CELLORGANE 5 Each 500-mg enteric coated tablet contains: Opotherapic cell extracts: Liver 50%, embryonic mesoderm 10%, Thymus 10%, Placenta 10%; Antioxidant enzyme complex: Superoxide dismutase, glutathione peroxidase, Glutathione reductase, glutathione transferase; Maltodextrin 20% and stabilizers.

Action Mechanisms

Formula components reach the cells directly or indirectly, in the case of oral products, by bloodstream, and are selectively incorporated into the cells through various means of cellular transport.
It acts revitalizing the renal system at the cellular level, improving its functionality and reducing the risk of degenerative diseases.

Contraindications

  • Allergies to animal proteins
  • Allergy to any of its components.
  • Pregnancy and lactation.

Posology

Incipient Renal failure, Diabetes Mellitus type II
Orally: Two tablets in the morning and 2 at night, for at least six months.
Hypertension, Anemia, mild to moderate Heart Failure, Aging
Orally: Two tablets in the morning and 2 at night, for at least three months.
The tablets are taken in the morning on an empty stomach and at night before dinner (30 minutes before meals).

Note:
The dose may be increased according to the clinical picture of the patient and the physician's discretion; the results depend on the completion of treatment.

Adjuvant treatment with:

Antihypertensive and heart failure
  • Calcium antagonists: Nifedipine
  • ACE inhibitors: Enalapril, Captopril
  • ARB-II: losartan, candesartan
  • Beta-blockers: Atenolol, Metoprolol, Carvedilol, Bisoprolol
  • Thiazide diuretics: Hydrochlorothiazide, chlorthalidone, indapamide, xipamide, Ameride (thiazide & K+ saver)
Hypoglycemic
  • Biguanides: Metformin
  • Inhibitors of alpha-glucosidase: Acarbose
  • Sulfonylureas: glibenclamide, glimepiride, glyburide and Tolazamide
  • Injectable drugs (like GLP-1): Sitagliptin, Saxagliptin, and linagliptin
  • Meglitinides: Repaglinide, nateglinide
  • SGLT2 Inhibitors: Dapagliflozin
  • Thiazolidinediones: Pioglitazone
  • DPP IV inhibitors: Sitagliptin and vildagliptin
  • Injectable insulin
Diuretics
  • Loop diuretics: Furosemide, Amiloride
  • Thiazide and analogues: IDEM (above)
  • K + Savers: Spironolactone
  • Osmotic: Mannitol
Statins

Selective, competitive inhibitors of HMG-CoA reductase: atorvastatin, simvastatin, pravastatin

Coronary vasodilators
  • Antianginal: Calcium antagonists - Nifedipine
  • Competitive antagonist of beta 1 and beta 2 adrenergic receptors: Propranolol
Heart failure Digitalis: Digoxin
Venous insufficiency
  • Venotonic and vasculoprotective drugs: Diosmin, Hidrosmin, Horse Chestnut Seed
Anti-anemic Iron
Renal impairment Recombinant erythropoietin, Furosemide, Amino Acids
Erectile dysfunction (ED) cyclic GMP-specific phosphodiesterase type 5 (PDE5): Sildenafil
© 2017 Biocell Ultravital. Privacy
Like Us on Facebook Follow Us on Twitter